| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 118,922 | 102,335 | 98,507 | 116,229 | | Cost of Revenue | 74,450 | 66,298 | 69,793 | 88,114 | | | Gross Profit | 44,472 | 36,037 | 28,714 | 28,115 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,453 | 30,243 | 26,697 | 26,762 | | Non Recurring | 2,443 |
-
| 2,289 | 2,916 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,576 | 5,794 | (272) | (1,563) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 395 | 576 | 1,607 | (438) | | Earnings Before Interest And Taxes | 8,971 | 6,370 | 1,335 | (2,001) | | Interest Expense | 1,356 | 1,538 | 1,242 | 1,423 | | Income Before Tax | 7,615 | 4,832 | 93 | (3,424) | | Income Tax Expense | 2,747 | 1,567 | (251) | (871) | | Minority Interest |
-
|
-
|
-
| (67) | | | | Net Income From Continuing Ops | 5,423 | 3,492 | 202 | (2,722) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,423 | 3,492 | 202 | (2,722) | | Preferred Stock And Other Adjustments | (371) | (258) | (200) |
-
| | | Net Income Applicable To Common Shares | $5,052 | $3,234 | $2 | ($2,722) |
|
0.22% Nasdaq 
Income Statement
